Blocking IL1RAP may weaken pancreatic cancer defenses before surgery

Blocking IL1RAP, a receptor that sits at a key control point in inflammatory signaling, can disrupt the tumor-driven inflammatory network that helps pancreatic cancer resist treatment, according to new research. Led by researchers at Sylvester Comprehensive Cancer Center, part of the University of M…

View Post on Scour ↗

More from Medical Xpress on Scour.

Covers 2 stories including Robert Egan - Science X